Benefix

Human Factor IX protein, produced by recombinant DNA technology for use in therapy of factor IX deficiency, known as hemophilia B or Christmas disease. Benefix (Recombinant) is a glycoprotein with an approximate molecular mass of 55,000 Da consisting of 415 amino acids in a single chain. It has a primary amino acid sequence that is identical to the Ala 148 allelic form of plasma-derived factor IX.

Benefix - Pharmacology:

Cleaves the Arg-Ile bond in Factor X to form active factor Xa leading to coagulation and clotting.

Benefix mini report

Benefix BLA
BLA - A product marketed under an approved Biologic License Application
Benefix PLASMA DERIVATIVE
PLASMA DERIVATIVE
Benefix global name
coagulation factor ix (recombinant)
Start - Stop data
START DATA:
1997-Feb-01
Start - Stop data
STOP DATA
not occurred

Benefix Interactions

Data is temporarily not available

Benefix Contraindications

Because BeneFIX, Benefix (Recombinant), is produced in a Chinese hamster ovary cell line, it may be contraindicated in patients with a known history of hypersensitivity to hamster protein.

 

Generic name, Overdose, Half Life Benefix, Food Interactions, Chemical, etc..

Benefix see also